Randomized placebo controlled Phase III trial to evaluate the reduction effects of functional foods (AHCC) on the adverse effects of digestive tract cancer chemotherapies and the investigation of the measurement method of cacogeusia
Phase 3
- Conditions
- digestive tract cancer
- Registration Number
- JPRN-UMIN000026461
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1)Continuous use of other functional foods 2)Serious complicating disorders (hepatic cirrhosis, insulin administration-diabetes, cardiac disease, interstitial lung disease, kidney disease, DIC, anemia) 3)Immunodeficiency, immunedepression 4)Pregnant or nursing women 5)Past medical history of drug allergies 6)Active infectious disease 7)Past medical history of alcoholic intoxications and mental disorders 8)Inappropriate for this study judged by the attending physician 9)Under 20 years old and the adults with no capacity of judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation for adverse effects and taste disturbance of chemotherapy
- Secondary Outcome Measures
Name Time Method